Perforin-dependent direct cytotoxicity in natural killer cells induces considerable knockdown of spontaneous lung metastases and computer modelling-proven tumor cell dormancy in a HT29 human colon cancer xenograft mouse model
暂无分享,去创建一个
Udo Schumacher | Anja Bethge | Gero Wedemann | U. Schumacher | G. Wedemann | Tobias Brodbeck | Nina Nehmann | N. Nehmann | T. Brodbeck | A. Bethge | Gero Wedemann
[1] C. Biron. Activation and function of natural killer cell responses during viral infections. , 1997, Current opinion in immunology.
[2] I. Melero,et al. Cellular liaisons of natural killer lymphocytes in immunology and immunotherapy of cancer , 2007, Expert opinion on biological therapy.
[3] R. Solana,et al. Human NK cells in acute myeloid leukaemia patients: analysis of NK cell-activating receptors and their ligands , 2011, Cancer Immunology, Immunotherapy.
[4] L. Lahiry,et al. Theaflavins target Fas/caspase-8 and Akt/pBad pathways to induce apoptosis in p53-mutated human breast cancer cells. , 2010, Carcinogenesis.
[5] H. Kato,et al. Cellular immunologic parameters related to age, gender, and stage in lung cancer patients. , 2000, Lung cancer.
[6] M. Caligiuri,et al. Human natural killer cells. , 2008, Blood.
[7] V. Stewart,et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement , 1992, Cell.
[8] Udo Schumacher,et al. Are Metastases from Metastases Clinical Relevant? Computer Modelling of Cancer Spread in a Case of Hepatocellular Carcinoma , 2012, PloS one.
[9] U. Schumacher,et al. Quantitative assessment of spontaneous lung metastases of human HT29 colon cancer cells transplanted into SCID mice. , 2000, Cancer letters.
[10] Erna Aescht,et al. Romeis - Mikroskopische Technik , 2010 .
[11] S. Eccles. Basic principles for the study of metastasis using animal models. , 2001, Methods in molecular medicine.
[12] I. Kimber. Natural killer cells. , 1985, Medical laboratory sciences.
[13] R. Ueda,et al. Immune function in mice lacking the perforin gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[14] S. Cullen,et al. Mechanisms of granule-dependent killing , 2008, Cell Death and Differentiation.
[15] M. A. Sáez,et al. The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma , 1997, Cancer.
[16] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[17] J. Seebach,et al. Natural killer cells in xenotransplantation , 1997 .
[18] A. Jemal,et al. Global Cancer Statistics , 2011 .
[19] R K Craig,et al. Methods in molecular medicine. , 1987, British medical journal.
[20] N. Shigesada,et al. A dynamical model for the growth and size distribution of multiple metastatic tumors. , 2000, Journal of theoretical biology.
[21] R. Yirmiya,et al. Stress increases metastatic spread of a mammary tumor in rats: Evidence for mediation by the immune system , 1991, Brain, Behavior, and Immunity.
[22] G. Trinchieri,et al. Human natural killer cells. , 1979, Transplantation proceedings.
[23] U. Schumacher,et al. Comparison of two techniques for the screening of human tumor cells in mouse blood: quantitative real-time polymerase chain reaction (qRT-PCR) versus laser scanning cytometry (LSC). , 2010, Acta histochemica.
[24] U. Schumacher,et al. Increased numbers of spontaneous SCLC metastasis in absence of NK cells after subcutaneous inoculation of different SCLC cell lines into pfp/rag2 double knock out mice. , 2009, Cancer letters.
[25] M. Caligiuri,et al. Innate or Adaptive Immunity? The Example of Natural Killer Cells , 2011, Science.
[26] J. Blay,et al. Natural killer cell IFN-gamma levels predict long-term survival with imatinib mesylate therapy in gastrointestinal stromal tumor-bearing patients. , 2009, Cancer research.
[27] M. Koch,et al. Natural Killer Cells are Scarce in Colorectal Carcinoma Tissue Despite High Levels of Chemokines and Cytokines , 2011, Clinical Cancer Research.
[28] R. Rosenfeld. Patients , 2012, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[29] N. Saijo,et al. Analysis of metastatic spread and growth of tumor cells in mice with depressed natural killer activity by anti-asialo GMl antibody or anticancer agents , 2005, Journal of Cancer Research and Clinical Oncology.
[30] Eric Vivier,et al. Natural Killer Cell Signaling Pathways , 2004, Science.
[31] C. Borner,et al. The biology of cytotoxic cell granule exocytosis pathway: granzymes have evolved to induce cell death and inflammation. , 2009, Microbes and infection.
[32] Kazuyoshi Takeda,et al. New aspects of natural-killer-cell surveillance and therapy of cancer , 2002, Nature Reviews Cancer.
[33] C. Blomqvist,et al. The expression of p53, bcl-2, bax, fas and fasL in the primary tumour and lymph node metastases of breast cancer , 2009, Acta oncologica.
[34] M. Peitsch,et al. Perforin and granzymes: crucial effector molecules in cytolytic T lymphocyte and natural killer cell-mediated cytotoxicity. , 1995, Current topics in microbiology and immunology.
[35] K. Arihiro,et al. Mechanistic analysis of the antitumor efficacy of human natural killer cells against breast cancer cells , 2012, Breast Cancer Research and Treatment.
[36] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[37] Lewis L Lanier,et al. Natural killer cells and cancer. , 2003, Advances in cancer research.
[38] R. Wiltrout,et al. Role of NK cells in the control of metastatic spread and growth of tumor cells in mice , 1982, International journal of cancer.
[40] Mark J. Smyth,et al. Functional significance of the perforin/granzyme cell death pathway , 2002, Nature Reviews Immunology.
[41] K. Magnusson,et al. Small intestinal differentiation in human colon carcinoma HT29 cells has distinct effects on the lateral diffusion of lipids (ganglioside GM1) and proteins (HLA Class 1, HLA Class 2, and neoplastic epithelial antigens) in the apical cell membrane , 1990, Journal of cellular physiology.
[42] S. Kumar,et al. Genetic background and tumour susceptibility in mouse models , 2013, Cell Death and Differentiation.
[43] M. Gellert. V(D)J recombination: RAG proteins, repair factors, and regulation. , 2002, Annual review of biochemistry.
[44] H. Ljunggren,et al. In search of the 'missing self': MHC molecules and NK cell recognition. , 1990, Immunology today.
[45] R. Ruggiero,et al. Concomitant tumor resistance. , 2012, Cancer letters.
[46] A. Watson,et al. Colon Cancer: A Civilization Disorder , 2011, Digestive Diseases.
[47] J. Aguirre-Ghiso,et al. Models, mechanisms and clinical evidence for cancer dormancy , 2007, Nature Reviews Cancer.
[48] Eric O Long,et al. Line of attack: NK cell specificity and integration of signals. , 2008, Current opinion in immunology.
[49] H. Mellstedt,et al. Natural killer (NK) cell function is a strong prognostic factor in colorectal carcinoma patients treated with the monoclonal antibody 17‐1A , 2003, International journal of cancer.
[50] A. Balmain,et al. Guidelines for the welfare and use of animals in cancer research , 2010, British Journal of Cancer.
[51] A. Atala. Re: TRAIL-Coated Leukocytes that Kill Cancer Cells in the Circulation , 2014 .
[52] A. Nussler,et al. Reduced NK-Cell Activity in Patients with Metastatic Colon Cancer , 2007 .
[53] M. Caligiuri,et al. Human natural killer cell development and biology. , 2006, Blood reviews.
[54] G. Trinchieri,et al. Biology of Natural Killer Cells , 1989, Advances in Immunology.
[55] R. Vessella,et al. Cancer micrometastasis and tumour dormancy , 2008, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.